You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
創勝集團-B(06628.HK)成功投得蘇州一幅地塊 以建設新的生產設施以滿足擴張需求
格隆匯 10-18 20:44

格隆匯10月18日丨創勝集團-B(06628.HK)發佈公吿,公司全資附屬公司邁博斯生物醫藥(蘇州)有限公司近期透過蘇州工業園區規劃建設委員會(賣方)主持的公開掛牌競價成功投得於網上掛牌出讓位於中國江蘇省蘇州工業園區,編號為320513102208GB88209的一幅地塊的國有建設用地使用權,並於2021年10月11日與賣方就正式收購該地塊訂立合約,總代價為人民幣1704萬元。邁博斯生物於2021年10月14日取得該地塊的不動產權證書。

該地塊位於中國江蘇省蘇州工業園區青丘街西、鍾園路北,總地盤面積約46,174.26平方米,許可容積率為2.5至3.0。該地塊指定為工業用途,使用年限為30年。

公司擬使用該地塊建設新的生產設施以滿足現有及即將到來的產品管線不斷擴張的需求。新設施將利用公司的連續流生物工藝(ICB)平台開發及生產臨牀試驗材料以及商業產品,以支持公司於全球市場推出獲批產品。新設施主要為原料藥生產的持續生物製造而設計,可同時處理傳統流加生產工藝。新設施亦將配備高速商業灌注及包裝藥品產品線。鑑於該地塊的位置及指定用途,董事會認為收購事項符合公司的業務發展策略及計劃,按公平合理的正常商業條款進行,並符合公司及其股東的整體利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account